Dr Michael B Shvarts, MD | |
110 Irving St Nw, Washington, DC 20010-3017 | |
(202) 877-7000 | |
Not Available |
Full Name | Dr Michael B Shvarts |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 12 Years |
Location | 110 Irving St Nw, Washington, District Of Columbia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003163684 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Medstar Washington Hospital Center | Washington, DC | Hospital |
Medstar Franklin Square Medical Center | Baltimore, MD | Hospital |
Medstar Southern Maryland Hospital Center | Clinton, MD | Hospital |
Medstar Union Memorial Hospital | Baltimore, MD | Hospital |
Medstar Saint Mary's Hospital | Leonardtown, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Medstar Medical Group Radiology Llc | 1557589157 | 161 |
News Archive
A new bio-inspired approach to synthesising polymers will offer unprecedented control over the final polymer structure and yield advances in nanomedicine, researchers say.
Jiayuh Lin, PhD, and colleagues at Nationwide Children's Hospital have developed a drug to target the most common cancerous bone tumor in children, osteosarcoma, using a version of the FDA-approved drug, Celebrex. The team will soon begin testing the drug using human and canine tumor cell lines thanks to a two-year, $200,000 grant from Alex's Lemonade Stand Foundation for Childhood Cancer.
Patterson Companies, Inc. today reported consolidated sales of $789,579,000 for the first quarter of fiscal 2010 ended July 25, an increase of 6% from $743,859,000 in the year-earlier quarter. The strong performance of technology offerings in the dental equipment business, as well as higher sales of veterinary supplies, helped offset the impact of the weak economy on other portions of Patterson's business. Acquisitions, net of negative foreign currency adjustments, accounted for the majority of the first quarter sales growth. Net income was $45,057,000 or $0.38 per diluted share, compared to $45,964,000 or $0.39 per diluted share in the first quarter of 2009.
The well-known research on uterine transplantation in Gothenburg is now supported by robotic surgery. This change has made operating on the donors considerably less invasive. After the technical modification, a first woman is now pregnant.
Nearly 83.5% of all the orthopedic procedures performed in the US are estimated to be delayed, postponed or canceled due to COVID-19, as they are considered to be elective and non-essential, according to GlobalData, a leading data and analytics company.
› Verified 9 days ago
Entity Name | Community Radiology Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396707782 PECOS PAC ID: 5991692444 Enrollment ID: O20040301000769 |
News Archive
A new bio-inspired approach to synthesising polymers will offer unprecedented control over the final polymer structure and yield advances in nanomedicine, researchers say.
Jiayuh Lin, PhD, and colleagues at Nationwide Children's Hospital have developed a drug to target the most common cancerous bone tumor in children, osteosarcoma, using a version of the FDA-approved drug, Celebrex. The team will soon begin testing the drug using human and canine tumor cell lines thanks to a two-year, $200,000 grant from Alex's Lemonade Stand Foundation for Childhood Cancer.
Patterson Companies, Inc. today reported consolidated sales of $789,579,000 for the first quarter of fiscal 2010 ended July 25, an increase of 6% from $743,859,000 in the year-earlier quarter. The strong performance of technology offerings in the dental equipment business, as well as higher sales of veterinary supplies, helped offset the impact of the weak economy on other portions of Patterson's business. Acquisitions, net of negative foreign currency adjustments, accounted for the majority of the first quarter sales growth. Net income was $45,057,000 or $0.38 per diluted share, compared to $45,964,000 or $0.39 per diluted share in the first quarter of 2009.
The well-known research on uterine transplantation in Gothenburg is now supported by robotic surgery. This change has made operating on the donors considerably less invasive. After the technical modification, a first woman is now pregnant.
Nearly 83.5% of all the orthopedic procedures performed in the US are estimated to be delayed, postponed or canceled due to COVID-19, as they are considered to be elective and non-essential, according to GlobalData, a leading data and analytics company.
› Verified 9 days ago
Entity Name | Physician Imaging Of Washington Hospital Center Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831385871 PECOS PAC ID: 6204910292 Enrollment ID: O20080229000143 |
News Archive
A new bio-inspired approach to synthesising polymers will offer unprecedented control over the final polymer structure and yield advances in nanomedicine, researchers say.
Jiayuh Lin, PhD, and colleagues at Nationwide Children's Hospital have developed a drug to target the most common cancerous bone tumor in children, osteosarcoma, using a version of the FDA-approved drug, Celebrex. The team will soon begin testing the drug using human and canine tumor cell lines thanks to a two-year, $200,000 grant from Alex's Lemonade Stand Foundation for Childhood Cancer.
Patterson Companies, Inc. today reported consolidated sales of $789,579,000 for the first quarter of fiscal 2010 ended July 25, an increase of 6% from $743,859,000 in the year-earlier quarter. The strong performance of technology offerings in the dental equipment business, as well as higher sales of veterinary supplies, helped offset the impact of the weak economy on other portions of Patterson's business. Acquisitions, net of negative foreign currency adjustments, accounted for the majority of the first quarter sales growth. Net income was $45,057,000 or $0.38 per diluted share, compared to $45,964,000 or $0.39 per diluted share in the first quarter of 2009.
The well-known research on uterine transplantation in Gothenburg is now supported by robotic surgery. This change has made operating on the donors considerably less invasive. After the technical modification, a first woman is now pregnant.
Nearly 83.5% of all the orthopedic procedures performed in the US are estimated to be delayed, postponed or canceled due to COVID-19, as they are considered to be elective and non-essential, according to GlobalData, a leading data and analytics company.
› Verified 9 days ago
Entity Name | Medstar Medical Group Radiology Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1326450156 PECOS PAC ID: 1557589157 Enrollment ID: O20140826000263 |
News Archive
A new bio-inspired approach to synthesising polymers will offer unprecedented control over the final polymer structure and yield advances in nanomedicine, researchers say.
Jiayuh Lin, PhD, and colleagues at Nationwide Children's Hospital have developed a drug to target the most common cancerous bone tumor in children, osteosarcoma, using a version of the FDA-approved drug, Celebrex. The team will soon begin testing the drug using human and canine tumor cell lines thanks to a two-year, $200,000 grant from Alex's Lemonade Stand Foundation for Childhood Cancer.
Patterson Companies, Inc. today reported consolidated sales of $789,579,000 for the first quarter of fiscal 2010 ended July 25, an increase of 6% from $743,859,000 in the year-earlier quarter. The strong performance of technology offerings in the dental equipment business, as well as higher sales of veterinary supplies, helped offset the impact of the weak economy on other portions of Patterson's business. Acquisitions, net of negative foreign currency adjustments, accounted for the majority of the first quarter sales growth. Net income was $45,057,000 or $0.38 per diluted share, compared to $45,964,000 or $0.39 per diluted share in the first quarter of 2009.
The well-known research on uterine transplantation in Gothenburg is now supported by robotic surgery. This change has made operating on the donors considerably less invasive. After the technical modification, a first woman is now pregnant.
Nearly 83.5% of all the orthopedic procedures performed in the US are estimated to be delayed, postponed or canceled due to COVID-19, as they are considered to be elective and non-essential, according to GlobalData, a leading data and analytics company.
› Verified 9 days ago
Entity Name | Riverside Radiology And Interventional Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093718496 PECOS PAC ID: 8729976964 Enrollment ID: O20190301000864 |
News Archive
A new bio-inspired approach to synthesising polymers will offer unprecedented control over the final polymer structure and yield advances in nanomedicine, researchers say.
Jiayuh Lin, PhD, and colleagues at Nationwide Children's Hospital have developed a drug to target the most common cancerous bone tumor in children, osteosarcoma, using a version of the FDA-approved drug, Celebrex. The team will soon begin testing the drug using human and canine tumor cell lines thanks to a two-year, $200,000 grant from Alex's Lemonade Stand Foundation for Childhood Cancer.
Patterson Companies, Inc. today reported consolidated sales of $789,579,000 for the first quarter of fiscal 2010 ended July 25, an increase of 6% from $743,859,000 in the year-earlier quarter. The strong performance of technology offerings in the dental equipment business, as well as higher sales of veterinary supplies, helped offset the impact of the weak economy on other portions of Patterson's business. Acquisitions, net of negative foreign currency adjustments, accounted for the majority of the first quarter sales growth. Net income was $45,057,000 or $0.38 per diluted share, compared to $45,964,000 or $0.39 per diluted share in the first quarter of 2009.
The well-known research on uterine transplantation in Gothenburg is now supported by robotic surgery. This change has made operating on the donors considerably less invasive. After the technical modification, a first woman is now pregnant.
Nearly 83.5% of all the orthopedic procedures performed in the US are estimated to be delayed, postponed or canceled due to COVID-19, as they are considered to be elective and non-essential, according to GlobalData, a leading data and analytics company.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Michael B Shvarts, MD 10980 Grantchester Way Fl 5, Columbia, MD 21044-6097 Ph: (202) 451-6794 | Dr Michael B Shvarts, MD 110 Irving St Nw, Washington, DC 20010-3017 Ph: (202) 877-7000 |
News Archive
A new bio-inspired approach to synthesising polymers will offer unprecedented control over the final polymer structure and yield advances in nanomedicine, researchers say.
Jiayuh Lin, PhD, and colleagues at Nationwide Children's Hospital have developed a drug to target the most common cancerous bone tumor in children, osteosarcoma, using a version of the FDA-approved drug, Celebrex. The team will soon begin testing the drug using human and canine tumor cell lines thanks to a two-year, $200,000 grant from Alex's Lemonade Stand Foundation for Childhood Cancer.
Patterson Companies, Inc. today reported consolidated sales of $789,579,000 for the first quarter of fiscal 2010 ended July 25, an increase of 6% from $743,859,000 in the year-earlier quarter. The strong performance of technology offerings in the dental equipment business, as well as higher sales of veterinary supplies, helped offset the impact of the weak economy on other portions of Patterson's business. Acquisitions, net of negative foreign currency adjustments, accounted for the majority of the first quarter sales growth. Net income was $45,057,000 or $0.38 per diluted share, compared to $45,964,000 or $0.39 per diluted share in the first quarter of 2009.
The well-known research on uterine transplantation in Gothenburg is now supported by robotic surgery. This change has made operating on the donors considerably less invasive. After the technical modification, a first woman is now pregnant.
Nearly 83.5% of all the orthopedic procedures performed in the US are estimated to be delayed, postponed or canceled due to COVID-19, as they are considered to be elective and non-essential, according to GlobalData, a leading data and analytics company.
› Verified 9 days ago
Kimberly Smith, Radiology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 301-902-1073 | |
Joel Bowers, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1150 Varnum St Ne, Washington, DC 20017 Phone: 202-269-7000 | |
Krista Lyn Mcfarren, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3301 New Mexico Ave Nw, Suite 102, Washington, DC 20016 Phone: 202-966-0606 Fax: 202-244-6757 | |
Ranjith Vellody, MD Radiology Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Aaron Conard, Radiology Medicare: Not Enrolled in Medicare Practice Location: 5255 Loughboro Rd Nw, Washington, DC 20016 Phone: 240-366-7325 | |
Dr. Estelle Cooke-sampson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Ave Nw Ste 6101, Washington, DC 20060 Phone: 202-865-6679 Fax: 202-865-3138 |